Skip to content

STroke inpatient secOndary Prevention: current status and continuous care improvement

STroke inpatient secOndary Prevention: current status and continuous care improvement

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN17207064
Enrollment
1600
Registered
2007-04-26
Start date
2006-10-01
Completion date
Unknown
Last updated
2021-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischaemic stroke and Transient Ischaemic Attack (TIA) Circulatory System Ischaemic stroke

Interventions

The conception of this project is to organise the effective stroke secondary prevention program, which is initiated at hospitalisation, into the whole course of stroke care, thus improving the prophyl

Sponsors

Beijing Tiantan Hospital (China)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age equal to or older than 18 years 2. Ischaemic event (infarction/Transient Ischaemic Attack [TIA]) within two weeks 3. Diagnosis of infarction or TIA Infarction: a. sudden or rapid onset of focal ischaemic neurological impairments by all kinds of reasons b. the impairments last more than 24 hours TIA: a. sudden or rapid onset of focal ischaemic neurological impairments by all kinds of reasons b. the impairments are within 24 hours (the diagnosis could be made if the patient have one of the symptoms: amaurosis fugax, dysphasia, movement disorder such as weakness or clumsiness; but such symptoms as diplopia, scintillation, scotosis, vertigo, memory disorder and ataxia cannot support the diagnoses; the symptoms that may be caused by migraine are ruled out) 4. No matter which one it is, all have either a Computed Tomography (CT) or a Magnetic Resonance Imaging (MRI) scan, to preclude haemorrhage or other non-ischaemic nerve system diseases 5. All the diagnoses have been confirmed and registered by the research centre neurologist 6. Patient resident in Beijing for at least one year 7. Patient consents to follow up for at least one year 8. Mechanism of the event is probably infarction/TIA due to artery scleratheroma 9. More than one modifiable risk factors of Cardiovascular Disease (CVD) 10. The case collected in each research centre should be consecutive. Even the patients who qualified but reject to join in, should also be added in the sum and registered with the basic items such as name, sex, age

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Silent infarction without symptoms or focal signs 3. Venous infarction 4. Other causes of ischaemic stroke but not scleratheromic. For example, cardiac resource, hyper-coagulation, dissection, vasculitis, medical resource such as the complications of carotid endarterctomy or angiography, traumatic resource, aura migraine, epilepsy, other non-ischaemic stroke 5. Reject to join in the study 6. Event episode concomitant with cardiac disease, cardiac insufficiency, hepatosis, renal inadequacy, respiratory failure, malignant tumour etc., and anticipate not to accomplish the one year-follow up 7. Glasgow Coma Score (GCS) less than four

Design outcomes

Primary

MeasureTime frame
1. The coincidence with the therapeutic regimen 2. The compliance to the risk factor controls

Secondary

MeasureTime frame
The reoccurrence rate of vascular issues.

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026